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Available online 2 December 2015Benzodiazepines (BDZs) are anxiolytic drugs that impair memory acquisition. Previous studies using the plus-
maze discriminative avoidance task (PMDAT, which assesses memory and anxiety concomitantly) indicated
that the effects of BDZs on anxiety and acquisition are related to each other. The possible inﬂuence of the anxio-
lytic action of BDZs on their effects on memory retrieval and extinction are poorly understood. This is relevant
considering the relationship between aversivememories and anxiety disorders.Wedesigned amodiﬁedprotocol
of PMDAT that evaluates anxiety during retrieval and extinction of the task. MaleWistar rats were trained in the
PMDAT (plus-maze with two open and two enclosed arms) using a standard or a modiﬁed protocol. In the
standard protocol, the aversive stimuli were presented in one of the enclosed arms during training, and the an-
imal had free access to the whole apparatus. In the modiﬁed protocol, the open arms were blocked with glass
walls. Twenty-four hours after training, the animals subjected to each of the protocols were treated with saline
or 2.0 mg/kg of diazepam (DZP) 30 min before the test. There was a third session in the maze (retest) 24 h
after the test. During the test, DZP impaired and improved retrieval in rats that had been trained in the standard
and the modiﬁed protocol when compared to the respective saline-treated groups. In addition, treatment with
DZP prior to the test induced anxiolysis, but only in the animals that were not pre-exposed to the open arms
of the apparatus (modiﬁed protocol). In these animals, DZP impaired extinction, which was evaluated during
retest session. The impairing effect of DZP on extinction seems to be related to its anxiolytic action during the
test (extinction learning). Further, we suggest that aversive memory retrieval depends on both the treatment
and the arousal elicited by exposure to the apparatus.
© 2015 Elsevier Inc. All rights reserved.Keywords:
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Some anxiety disorders, such as post-traumatic stress disorder
(PTSD), panic disorder and phobias, involve some extent ofmaladaptive
mnemonic features (Ferreri et al., 2011; Milad et al., 2006; Rubin et al.,
2008). In these disorders, a trigger stimulus, which might be conscious
or unconscious, associated to a past traumatic episode — evokes an
abnormal and/or excessive anxiety response (American Psychiatric
Association, 2013). Indeed, even generalized anxiety disorder patients
presents underlying negative implicit associations with neutral or
negative attributes (Reinecke et al., 2010). Thus, understanding theus-maze; MOD, modiﬁed proto-
AV%, percent time spent in the
s; STD, standard protocol.
logia, Universidade Federal de
062 São Paulo, São Paulo, Brazil.relationship between aversive memories and anxiety is imperative to
stablish the appropriate therapeutic approach to each anxiety disorder.
Although other pharmacological strategies have emerged to treat
such disorders, the benzodiazepines (BDZs) are still widely used for
alleviating acute distress symptoms or in combination with other anxi-
olytics, such as selective serotonin reuptake inhibitors (Bandelow et al.,
2008). However, BDZs impair aversive memory extinction in PTSD pa-
tients (Gelpin et al., 1996; Matar et al., 2009; Mellman et al., 2002;
Zohar et al., 2011). Also, memory deﬁcits and cognitive impairment
are observed in patients chronically treated with BDZs (CADTH, 2014).
Studies have shown that BDZs impair memory acquisition in
humans and in rodent models (Beracochea, 2006; McNamara and
Skelton, 1991; Savić et al., 2005). However, the effects of BDZs on aver-
sivememory retrieval are poorly understood. Previous literature reports
contradictory results, showing that BDZs enhance (File et al., 1999;
Obradović et al., 2004), impair (Borde et al., 1997, 1996) or have no ef-
fects (Chapouthier and Venault, 2002; Venault et al., 1986) on memory
retrieval. On the other hand, BDZs have been clearly shown to impair
aversive memory extinction (Hart et al., 2009; Matar et al., 2009).
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on both emotional and mnemonic processes, and the relevance of the
anxiolytic effects of BDZs to mnemonic processes is unknown. Indeed,
the interaction between these two effects could be relevant to the inter-
pretation of the results in aversive conditioning tasks (Pain et al., 2002;
Silva and Frussa-Filho, 2000). Thus, further research to understand how
the anxiolytic effect of BDZ interacts with aversive memory retrieval
and extinction is necessary to advance the current knowledge on condi-
tioned fear-related disorders.
The plus-maze discriminative avoidance task (PMDAT) is an adapta-
tion of the conventional elevated plus-maze that has been used to assess
anxiety and memory-related behaviors concomitantly (Calzavara et al.,
2004; Kameda et al., 2007; Munguba et al., 2011; Ribeiro et al., 2011;
Silva and Frussa-Filho, 2000). During the ﬁrst trial (training) of this
two-trial task, one of the enclosed arms is paired with aversive stimuli
every time the animal enters it. The stimuli are light and noise, which
are not presented in the second trial (test session). Retrieval of the
task is evaluated by comparing the time spent in each enclosed arm
(aversive and non-aversive) during the second trial. Amnestic (Patti
et al., 2006; Silva et al., 1999) and memory-enhancing (Claro et al.,
1999; Silva et al., 1997)manipulations decrease and increase the avoid-
ance of the aversive arm in the test session, respectively. Concomitantly,
anxiety-like behavior is evaluated by the time spent in the open arms of
the apparatus during the training session (Silva and Frussa-Filho, 2000).
Therefore, the paradigm enables the study of the possible relationships
between memory and anxiety. Pre-training administrations of chlordi-
azepoxide and caffeine in rodents have anxiolytic and anxiogenic
effects, respectively, and both manipulations impair learning in this
task, suggesting that aversive memory acquisition is dependent on an
optimal anxiety level during the conditioning phase (Silva and Frussa-
Filho, 2000). Further, previous studies have indicated that the impair-
ment in acquisition induced by BDZs is highly dependent on the
presence of their anxiolytic effect during the training in the PMDAT
(Calzavara et al., 2004; Silva and Frussa-Filho, 2000).
One important limitation of the use of PMDAT is that the anxiolytic
effect of some pharmacological agents (mainly BDZs) is weakened, or
even absent, during the second trial in the apparatus. This is a conse-
quence of the one-trial tolerance (OTT) that is induced by the exposure
to the apparatus in the training session (Silva and Frussa-Filho, 2000).
This phenomenon is also described to the conventional elevated plus-
maze (EPM), and deﬁned as the loss of the anxiolytic effect of benzodi-
azepines (BDZs) on rodents previously exposed to the EPM (File, 1990;
File et al., 1990).
The absence of an anxiolytic action of BDZs on rodents pre-exposed
to the PMDAT precludes the investigation of possible relationships be-
tween the effects of BDZs on anxiety and retrieval or extinction. In this
sense, studies support the view that one-trial tolerance depends on
the prior exploration of relatively safe areas of the maze and the reten-
tion of information from the ﬁrst trial. Such learning would prevent the
presence of novelty, and the loss of BDZ efﬁcacy on the second trial
would reﬂect absence of an approach/avoidance conﬂict (Bertoglio
and Carobrez, 2000; Rodgers and Shepherd, 1993; Roy et al., 2009).
Therefore, amodiﬁcation of the original protocol that allows the reliable
assessment of anxiety-like behavior during the second exposition in the
PMDAT would be useful to the investigation of possible relationships
between retrieval/extinction and anxiety.
This investigation is required because the anxiolytic activity of a
compound is often measured by the ability to prevent aversive condi-
tioned responses. That is the case of tests such as fear-potentiated startle
(Brown et al., 1951; Davis, 1986), Vogel water-lick conﬂict (Petersen
and Lassen, 1981; Vogel et al., 1971) and context-conditioned freezing
(Beck and Fibiger, 1995; Fanselow and Helmstetter, 1988; Malkani
and Rosen, 2000; Resstel et al., 2006). These tests do not dissociate in-
nate from learned fear responses, because the same behavioral outcome
is expected in both cases. Therefore, a speciﬁc activity upon innate fear
cannot be dissociated from the impairing effects on conditioned fearresponses. An animal model able to address both innate and learned
fear responses could be useful to the screening for novel therapeutic
agents aswell as to the understanding of the pathophysiology of anxiety
disorders.
Brieﬂy, the PMDAT address the effects of treatments on both innate
and learned fear responses, evaluated by different behavioral outcomes.
This dissociation is relevant because these responses rely on different
neural pathways (for review, see (Gross and Canteras, 2012)). Indeed,
as demonstrated in the study by Ribeiro et al. (2011), the inactivation
of the basolateral amygdala (BLA) impaired aversive memory acquisi-
tion, but not the innate fear response in the PMDAT.
Furthermore, the PMDAT has an ethical advantage compared to
other aversive conditioning paradigms. The conditioning in the training
session is conducted through the presentation of mild stimuli (i.e. light
and noise), while most of other associative learning paradigms com-
prise painful stimuli (Davis, 1986; Resstel et al., 2006; Vogel et al.,
1971). As well, the nature of the aversive stimuli in the PMDAT is closer
to rodent's natural aversive behavioral repertory. That is, strong light
and loud noises relate closer to aversive environmental expositions
than electrical shocks or other painful stimuli in rodents. Hence, the
PMDAT also relates closer to a natural aversive condition in humans,
which is a desirable feature to emulate disorders with aversive
associations.
The aim of the present study was to verify the effects of the BDZ di-
azepam (DZP) on aversive memory retrieval and extinction in rats sub-
jected to the PMDAT. In order to evaluate anxiety-related behaviors on
the second trial of the PMDAT,we designed a protocol to prevent the oc-
currence of one-trial tolerance. In the modiﬁed protocol, the open arms
were blocked with transparent glass walls during the training session,
precluding the exploration of these areas of the maze. The test was car-
ried out without protocol modiﬁcations, and we added a third session
(identical to the test session) at the end of the experiment to assess
aversive memory extinction.
2. Materials and methods
2.1. Animals
Three-month-old Wistar male rats (250–300 g) were housed in
groups of four in plastic-walled cages (45 × 35 × 15 cm), under con-
trolled temperature (23 ± 1 °C) and lighting (12:12 h light–dark
cycle; lights on at 6:00 am). The animals had free access to food and
water, and were exposed to 5 min of gentle handling for 7 days prior
to the experiment. All tests were performed during the light period
(1:00 to 5:00 p.m.), and animals were pseudo-randomly assigned to
each group in order to include at least one animal of each group per
cage.
All procedures were approved by the Committee on Animal Re-
search and Ethics of the Federal University of Rio Grande do Norte and
are in accordance with the Brazilian law for animal experimentation
(Law 11.794). All efforts were taken to minimize pain, suffering, dis-
comfort, and the number of animals used.
2.2. Plus-maze discriminative avoidance task (PMDAT)
The PMDAT was conducted in a modiﬁed elevated plus-maze that
was made of wood, with two enclosed (50 × 15 × 40 cm) opposing
two open (50 × 15 cm) arms. A 100W lamp and a speaker were placed
over one of the enclosed arms (aversive enclosed arm).
The behavioral protocol is schematized in Fig. 1. The rats were ex-
posed to three trials. During the training session, each ratwas placed in-
dividually in the center of the apparatus, facing the intersection
between the open arms, and allowed 10 min of free exploration. Every
time an animal entered with all four paws into the aversive enclosed
arm, the 100W light (1500 lx at themaze ﬂoor level) and a digitally pro-
duced 80 dBwhite noisewere turned on until the animal left the arm. In
Fig. 1. Schematic diagram of the protocol and treatment schedule. AV, aversive arm; NAV, non-aversive arm; OP, open arm. Dashed lines represent the glass walls.
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version of the PMDAT. In the modiﬁed version, the open arms were
blocked with transparent glass walls to prevent exploration (Fig. 1),
which allowed visual access to spatial cues (window and poster on
the wall). The percentage of time that was spent in the aversive
enclosed arm (throughout the total duration and 200 s epochs) in the
training session was used as a measure of learning. Thus, we expect
that an animal that learned the taskwould reduce its spontaneous visits
to the aversive arm throughout training session epochs, and discrimi-
nate the enclosed arms in total session data.
The test session was performed 24 h later. All animals were re-
exposed to the regular apparatus (without the glass walls) for 10 min
and the aversive stimuli were no longer presented. The time spent in
the aversive enclosed arm during the test was used as a measure of
the retrieval of the aversive information.
A third session (retest), identical to the test session, was conducted
24 h later to assess extinction retrieval.
The apparatus was cleaned with a 5% alcohol solution before each
behavioral session. The sessions were recorded with a digital camera
that was placed above the apparatus. The behavioral sessions were
monitored using an animal tracking software (ANY-maze, Stoelting,
USA) on a computer screen that was placed in another room.
The time spent in the aversive enclosed arm, the neutral enclosed
arm and the open arms (except for the group exposed to the modiﬁed
plus-maze in the training session) were measured during all sessions.
The percentage of time spent in the aversive (%TAV) and open arms
(%TOA) were calculated by the formulae (time in aversive arm / time
in aversive arm + time in non-aversive arm) ∗ 100 and (time in open
arms / time in aversive arm + time in non-aversive arm + time in
open arm) ∗ 100, respectively. Memory retention was evaluated by
comparing the %TAV versus exploration of enclosed arms (aversive
and non-aversive arms) by chance (50%). A poor performance is
characterized by exploration of the two enclosed arms at the level
of chance (50% for each arm). Therefore, a signiﬁcant difference
from chance represents discrimination of the aversive arm. Anxiety-
like behavior was evaluated by the percentage of time that was spent
in the open arms (%TOA) across the total session as well as in the ﬁrst
5 min of each session. This time–window analysis was chosen on the
basis of previous data showing that 5 min is the appropriate period to
evaluate the anxiolytic effects of BDZs in the PMDAT, due to the
possibility of acquisition of OTT within a 10-min session (Silva and
Frussa-Filho, 2000). Locomotor activity was measured by the distance
traveled in the apparatus.
2.3. Drug administration and experimental groups
Diazepam (DZP, Valium®, Roche, Brazil) was dissolved in physiolog-
ical salinewith 2% Tween-80, whichwas used as control solution. Thirty
minutes before the test session (see Section 2.2), animals that have been
exposed to either the standard (STD) or modiﬁed (MOD) protocol (in
the training) received saline (STD/SAL =12 and MOD/SAL =12) or2 mg/kg of DZP (STD/DZP = 10 and MOD/DZP = 10) intraperitoneally
(i.p.), in a volume of 1 ml/kg of body weight (Fig. 1). Previous studies
have demonstrated the anxiolytic action of this dose in the conventional
elevated plus-maze (Almeida et al., 1991; Guimarães et al., 1990;
Taukulis and Goggin, 1990). In addition, we have recently conducted
a dose–response curve of DZP in the PMDAT as part of another
study (Silva et al., unpublished data). We found that DZP presents
anxiolytic action in this paradigm when given at 2 and 4 mg/kg, but
not 1 mg/kg.2.4. Statistical analysis
Data normality and the homogeneity of variances were tested by
Kolmogorov–Smirnov and Levene's tests, respectively. Comparisons be-
tween the percentage of time that was spent in the aversive enclosed
arm (%TAV) and exploration of the enclosed arms by chance (50%)
were conducted with one-sample t-tests to determine whether the an-
imals discriminated aversive arm. Bonferroni correction was applied to
reduce type I error due to multiple comparisons; therefore, the signiﬁ-
cance level was set at p b 0.0125 for this analysis. Comparisons between
groups to all parameters were performed by a two-way analysis of var-
iance (ANOVA) with the type of protocol and treatment as between-
subjects factors, or a three-way ANOVA with repeated measures with
time epochs throughout session as within factor and type of protocol
and treatment as between factor. A post-hoc comparison with Sidak's
test was conducted to detect differences in themagnitude of the effects.
Independent sample t-tests were applied to yield differences between
groups to total distance traveled and %TOA data during training session.
Signiﬁcance level was set at p b 0.05. All statistical analyses were con-
ducted with PASW Statistics 18 software (IBM, USA).3. Results
3.1. Learning and memory: aversive enclosed arm exploration
3.1.1. Training session: acquisition
One-sample t-tests on the total session datawith the test value set to
50% (i.e., exploration of the aversive armby chance) and Bonferroni cor-
rection for multiple comparisons revealed that all groups learned the
task [STD/SAL: t(12) = 113.14; STD/DZP: t(10) = 94.79; MOD/SAL
t(12) = 136.04; MOD/DZP: t(10) = 70.80; p b 0.001]. Accordingly,
two-way ANOVA to total session did not ﬁnd signiﬁcant differences
(Fig. 2A). A three-way ANOVA with repeated measures to time epochs
throughout the session revealed no signiﬁcant effect of the type of pro-
tocol, treatment group or interactions, only a signiﬁcant effect of time
epochs [F(2,80) = 71.364, p b 0.001]. Sidak's post-hoc test to the time
epoch effect revealed that all groups learned the task, as indicated by
comparisons between 0 and 200 s epoch to 200–400 s (p b 0.001) and
400–600 s (p b 0.001) (Fig. 2B).
Fig. 2. Total percentage of time spent in the aversive arm displayed by rats submitted to standard (STD) or modiﬁed (MOD) training protocols and treated with saline (SAL) or 2 mg/kg
diazepam (DZP) 30min prior to the test session (A). Percentage of time spent throughout 200 s epochs in training (B), test (C), and retest (C) sessions. Data are expressed as the mean±
S.E.M. #p b 0.0125 compared to exploration of aversive arm by chance (50%) (one-sample t-test). *p b 0.05 compared to respective SAL group; §p b 0.05 compared to STD/SAL group;
&p b 0.05 compared to respective 0–200 s epoch (ANOVA followed by Sidak's post hoc test).
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One-sample t-tests on the total session data revealed that all groups
discriminated the aversive arm [STD/SAL: t(12) = 19.28; STD/DZP:
t(10) = 5.40; MOD/SAL t(12) = 9.20; MOD/DZP: t(10) = 13.54; p b
0.001], which indicates that all groups retrieved the aversive memory
(Fig. 1A). However, a two-way ANOVA to total session revealed a signif-
icant interaction between treatment and type of protocol [F(1,44) =
12.269; p = 0.001]. A post-hoc comparison using Sidak's test revealed
that both the STD/SAL andMOD/DZP groups spent less time in the aver-
sive arm compared with the STD/DZP and MOD/SAL groups (p b 0.05)
(Fig. 2A). These results indicate that DZP treatment improved aversive
memory retrieval in the MOD protocol, but impaired retrieval in rats
trained in the STD protocol. This ﬁnding was conﬁrmed by a three-
way ANOVA with repeated measures to time epochs throughout
the session, which revealed a signiﬁcant interaction between time
epochs and type of protocol [F(2,80) = 915.329, p = 0.034] and be-
tween type of protocol and treatment [F(1,40) = 11.300, p = 0.002]
(Fig. 2C). Sidak's post-hoc test to the interaction between type of proto-
col and time epoch revealed that only STD group extinguished aversive
memory throughout test session, as indicated by comparisons between
0 and 200 s epoch to 200–400 s (p= 0.05) and 400–600 s (p= 0.019).
In Fig. 2C, it is clear that STD groups exhibited reduction in the avoid-
ance response to the aversive arm throughout the session compared
to MOD groups.3.1.3. Retest session: extinction
One-sample t-tests on the total session data (with test value as 50%)
with Bonferroni correction applied for multiple comparisons revealed
that only the MOD/DZP group discriminated the aversive arm [MOD/
DZP: t(10) = 11.93, p b 0.001], which indicates that DZP treatment im-
paired aversive memory extinction in rats trained in the MOD protocol.
Neither a two-way ANOVA to total session nor a three-way ANOVAwith
repeated measures to time epochs throughout session revealed signiﬁ-
cant differences (Fig. 2A,D).3.2. Anxiety: percentage of time in the open arms
In the training session, independent sample t-test to STD groups —
which had access to the open arms— found no effects for %TOA in nei-
ther of the time windows analyzed (ﬁrst 5 min and 10 min of session).
In the test session, a two-way ANOVA for the %TOA during the ﬁrst
5 min of the session revealed signiﬁcant effects of type of protocol
(MOD vs. STD) [F(1,44) = 13.448, p = 0.001] and the interaction be-
tween the type of protocol and treatment [F(1,44) = 3.864, p =
0.056]. Sidak's post-hoc test (p b 0.05) revealed differences to MOD/
DZP group compared to all other groups in the ﬁrst 5 min of session
(Fig. 3A), which indicates that on the STD protocol rats developed the
one-trial tolerance to the anxiolytic effect of DZP. Simply put, only ani-
mals submitted to the MOD protocol presented the proper anxiolytic
response to DZP, which indicates that OTT was prevented by the maze
modiﬁcation and that previous open arms experience indeed reduces
approach towards open arms (Fig. 3A). Thus, the MOD protocol
prevented the OTT phenomenon in the ﬁrst 5 min of test session. Fur-
thermore, data from the 10 min of session suggests that OTT was ac-
quired throughout the test session.
In the retest session, two-way ANOVAs on the %TOA during the
ﬁrst 5 and the whole 10 min of the session revealed signiﬁcant
effects of the treatment only in the 5 min of session [F(1,44) =
4.290; p = 0.045], with SAL groups spending more time in the open
arms than DZP groups. Sidak's post-hoc test did not yield any differ-
ences between groups.3.3. Motor activity: distance traveled in the apparatus
Independent t-tests to total distance traveled for the training session
showed no signiﬁcant difference of the type of protocol inmale rats, de-
spite reduced area to explore in theMOD protocol compared to the STD
protocol. A two-way ANOVA to the same variable to test and retest ses-
sion also did not ﬁnd any effect (Table 1).
Fig. 3.Percentage of time spent in open arms displayed in theﬁrst 5min (A) and thewhole
10min (B) of the test session by rats previously submitted to standard (STD) or modiﬁed
(MOD) training protocols and treated with saline (SAL) or 2 mg/kg diazepam (DZP)
30 min prior to the test session. Data are expressed as the mean ± S.E.M. *p b 0.05 com-
pared to all other groups (ANOVA followed by Sidak's post hoc test).
Table 2
Correlation between memory and anxiety parameters.
%TAV test %TAV retest
%TOA 10 min r= 0.29; p = 0.039⁎ r=−0.066; p = 0.65
%TOA 5 min r= 0.065; p = 0.65 r=−0.18; p = 0.19
⁎ p b 0.05 (Pearson's correlation test).
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Pearson's correlation testwas applied for the %TAV scores during the
test or retest session versus the %TOA scores during the 5 or 10 min of
the test session to detect whether an interaction exists between anxiety
and memory parameters. Results showed only a weak positive correla-
tion between %TAV during the test session versus %TOA in the entire
10min of the test session (p b 0.05, r=0.29; Table 2). Therefore, the ex-
ploration of the open arms during the test session appears to have little
or no inﬂuence on the exploration upon the aversive armduring the test
and retest sessions.4. Discussion
In this study, we found that animals learned the task properly irre-
spective of the type of protocol, as shown by both the total session
and time epochs during the training session (Fig. 2A,B). Accordingly, dif-
ferences to motor activity due to reduced area of the apparatus in the
modiﬁed protocol was not a major issue to exploratory behavior inTable 1
Total distance traveled in thewhole apparatus (mean±SEM)during all experimental ses-
sions displayed by rats submitted to standard (STD) ormodiﬁed (MOD) training protocols
and treatedwith saline (SAL) or 2 mg/kg diazepam (DZP) 30min prior to the test session.
Distance traveled (m)
Type of protocol Training Treatment Test Retest
STD 12.10 ± 0.82
SAL 9.86 ± 2.00 10.78 ± 2.46
DZP 13.56 ± 3.00 12.46 ± 2.88
MOD 10.73 ± 0.81
SAL 15.19 ± 1.04 13.01 ± 1.56
DZP 12.68 ± 2.59 11.12 ± 2.49
Data are expressed as mean ± SEM (independent sample t-tests).the training session (Table 1). Moreover, as expected due to absence
of DZP treatment, no differences were found to percent time in open
arms to groups in the standard protocol (Fig. 3A,B).
Data of the test session revealed that all groups retrieved the task,
which was measured by the ability to discriminate the aversive
enclosed arm during the test session (Fig. 2A, one-sample t-test). How-
ever, the magnitude of the retrieval varied between groups. We found
an interaction between type of protocol and treatment. Namely, DZP-
treated animals that trained in the standard and modiﬁed protocols
exhibited higher and lower retrieval magnitudes, respectively, when
compared with their respective controls (Fig. 2A). Additionally, MOD/
SAL group performed worse than STD/SAL group. Thus, change in the
protocol seemed to reduce discrimination between the enclosed arms
in the task. Furthermore, only animals that underwent training in the
standard protocol exhibited extinction behavior throughout the test
session (Fig. 2C).
The evaluation of anxiety during the test session revealed that the
type of protocol had inﬂuence in open arm exploration, with animals
under themodiﬁed protocol spendingmore time in the open arms. Fur-
ther, the anxiolytic effect of DZPwas expressed only under themodiﬁed
protocol (Fig. 3A). Indeed, DZPwas ineffective inmodifying the explora-
tion of the open arms in rats trained under the standard protocol of the
PMDAT. This result (absence of the anxiolytic effect of DZP) was expect-
ed due to the OTT phenomenon. Conversely, DZP-treated animals sub-
mitted to the modiﬁed protocol exhibited higher rates of open-arms
exploration in the ﬁrst 5 min of the test session when compared to all
other groups (Fig. 3A). Thus, preventing the exploration of the open
arms — but keeping the visuospatial cues and the conﬁguration of the
apparatus — leads to the maintenance of the approach/avoidance con-
ﬂict and eliminates the OTT to the anxiolytic effect of DZP. In addition,
the analysis of thedata from the entire 10-min session (Fig. 3B) revealed
that all groups explored the open arms similarly. This results demon-
strates the occurrence of one-trial tolerance to the effects of diazepam
within the session, which corroborates a previous report by Silva and
Frussa-Filho (2000).
Brieﬂy, saline-treated animals performed better after being trained
in the standard protocol compared with the modiﬁed protocol, while
DZP-treated animals trained under the modiﬁed protocol performed
similarly to the saline-treated animals trained under the standard pro-
tocol. Taken together, the ﬁndings for aversive memory in the test ses-
sion may be related to the inﬂuence of the optimal level of anxiety
that is necessary to retrieve the task. Prior studies have suggested that
optimal levels of anxiety are required for adequate performance on
the PMDAT (Calzavara et al., 2004; Silva and Frussa-Filho, 2000), as
well as in other aversive and working memory tasks (Calabrese, 2008;
Diamond et al., 2007; Mair et al., 2011). These ﬁndings could explain
the apparent contradictory effects of DZP on memory retrieval. In
other words, the absence of the approach/avoidance conﬂict during
the test session in the standard protocol might result in a downward
shift in general arousal. This view is corroborated by the fact that rats
exposed to the EPM presents crossed one-trial-tolerance to the light/
dark box (Rodgers and Shepherd, 1993) and antinociception (Lee and
Rodgers, 1990). A reduction in arousal could be potentiated by BDZs,
which would lead to a suboptimal anxiety level to perform the task.
Therefore, the presence of the approach/avoidance conﬂict during the
test session of rats trained under the modiﬁed protocol may preserve
the arousal that is elicited by the apparatus. In addition, the anxiolytic
manipulation during the test session may have improved the
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of anxiety to perform the task.
Collectively, these ﬁndings illustrates the inverse U-shaped optimal
arousal curve by Yerkes and Dodson (Yerkes and Dodson, 1908). That
is, DZP impaired the performance of animals that were trained in the
standard protocol by decreasing anxiety bellow the optimum level. At
the same time, the impairment in aversive memory retrieval induced
by themodiﬁed protocol was restored by DZP administration. This phe-
nomenon supports the view that the type of protocol and the treatment
act as opposing agents on the optimal arousal level to aversive memory
retrieval. Nevertheless, few studies have investigated the interaction of
arousal with BDZs action on memory retrieval and anxiety in humans.
For instance, studies in humans reports that the effects of the BDZ loraz-
epam onmemory are dose-dependent. That is, lorazepam impairs emo-
tional and episodic memory retrieval in doses higher than 1.5 mg/kg,
but facilitates memory retrieval when given at the 1.0 mg/kg dosage
(Brignell et al., 2007; File et al., 1999), which suggests a similar pattern
of optimal level of arousal to perform a memory task.
An alternative interpretation suggests that the increase in the explo-
ration of the open arms inﬂuenced the aversive arm exploration. How-
ever, only a weak positive correlation (r b 0.3) was detected between
%TAV and %TOA in the test session (Table 2). In addition, the %TOA
data across the total session shows that the exploration of the open
arms did not exceed 20% of the total time in the apparatus. As well, no
differences to total distance traveled were found for the test session.
Therefore, it seems unlikely that an increase in the exploration of the
open arms during the initial 5 min and/or motor activity in the test ses-
sion account for the reduced exploration of the aversive arm.
The analysis of the retest session revealed that animals extinguished
the aversive task, except for the DZP-treated animals that were trained
in themodiﬁed protocol. These animals continued to avoid the aversive
arm during the retest session (Fig. 2A). Previous studies have shown
that the administration of BDZ before the extinction learning (test ses-
sion in this study) blocks extinction (Bouton et al., 1990; Hart et al.,
2009). As mentioned, this could be of relevance in the context of treat-
ment of anxiety disorders related to aversive learningwith BDZ. Arousal
is associated with activation of the hypothalamic–pituitary–adrenal
(HPA) axis, and consequently with secretion of glucocorticoids. This re-
sponse is instrumental to adaptation to stress and is involved in the in-
stallment of phobic fear. Subjects who received cortisol 1 h before
exposure to phobic stimuli reported reduced fear (Soravia et al.,
2006). In contrast, BDZs reduces the activation of HPA axis and lower
the level of glucocorticoids after stress exposure (Matar et al., 2009).
That is, the disruption of this physiological coping mechanism might
be on the foundation of PTSDpathophysiology. In fact, chronic BDZ ther-
apy after traumatic events has been shown to facilitate PTSD installment
(Gelpin et al., 1996) or impair extinction learning in PTSD patients
(Rothbaum et al., 2014). Similarly, in an animal model of PTSD, admin-
istration of alprazolam 1 h after aversive stimuli exposition was associ-
ated with increased fear response compared to controls (Matar et al.,
2009). In accordance, we found that the administration of DZP under
an arousing context (i.e. exposition to the complete apparatus after
training in the modiﬁed protocol) could disrupt HPA axis response
and impair aversive memory extinction. Conversely, a less arousing
context (i.e. exposition to the standard protocol)would not result in im-
paired aversive memory extinction.
Alternatively, the phenomenon of state dependency could explain
the effects of DZP on extinction learning. For example, Bouton et al.
(1990) described that fear extinction is state-dependent to the effects
of DZP in a dose-dependent manner. This hypothesis holds that drug-
related cues are part of the context under which extinction learning oc-
curs. Therefore, the absence of the cues on a subsequent test could result
in a failure to retrieve the extinctionmemory. This failure is an example
of the renewal phenomenon, in which the shift of context between ex-
tinction learning and retrieval restores fear responses (Bouton andKing,
1983; Bouton and Ricker, 1994; Harris et al., 2000). In this context, theanxiolytic effect of DZP during the test session may represent the
drug-related cue during extinction learning in test session. Subsequent-
ly, the absence of the drug-related cue in retest session could have
restored the avoidance response to the aversive arm. Nevertheless —
based on the ﬁndings for anxiety parameters — if the extinction deﬁcit
was due to state dependency, one would expect that the STD–DZP
group did not extinguish aversive memory in the retest session as
well. Thus, it is questionable that the state-dependency phenomenon
account for the observed effect on aversive memory.
Finally, a possible explanation to this outcome is that the drug
disrupted the learning process that underlies extinction. A mechanism
by which the drug may have disrupted this learning is through the re-
duction in the levels of activity in the fear system. Contemporarymodels
propose that the inhibitory learning that occurs in extinction is regulat-
ed by the discrepancy between the fear elicited by the conditioned stim-
ulus and the absence of fear elicited by the new situation (no aversive
stimulus) (Osan et al., 2011). Therefore, reducing the levels of activity
in the fear system through the systemic administration of DZP would
reduce the discrepancy and impair the development of extinction
learning. This view is supported by ﬁndings that have been obtained
with intra-BLA inactivation with midazolam, muscimol, 2-amino-5-
phosphonopentanoic acid (APV) or bupivacaine (Hart et al., 2009; Kim
and Richardson, 2008; Laurent and Westbrook, 2008; Laurent et al.,
2008). The administration of each of these drugs impaired extinction
when infused before the extinction learning session. In addition, BLA ac-
tivity has been implicated in aversive memory acquisition on the
PMDAT (Munguba et al., 2011; Ribeiro et al., 2011). Once more, in
view of the exposed rationale, one would expected that DZP treatment
would impair aversive memory extinction to both DZP-treated groups.
The aforementioned views are rather additive than mutually exclu-
sive. All rationales are supported by the anxiety parameters that were
observed in the test session — only the animals that displayed DZP-
induced anxiolytic activity failed to exhibit extinction during the retest
session. In contrast to previous reports, the present study includes an
evaluation of anxiety levels concomitant to the evaluation of retrieval,
which dissociates the confounding factor of anxiety that is present in
most of the fear conditioning models.
Of notice, sedation has been indicated as an important confounding
factor in memory and anxiety models that are based on conditioned re-
sponses (Hart et al., 2009; Resstel et al., 2006). Differently from most
studies, we also controlled for the motor behavior effects of DZP or
type of protocol manipulations. In the present study, we demonstrated
that neither the dose of DZP used in the study (2.0 mg/kg) nor the type
of protocol induced differences in motor activity during the test and re-
test sessions (Table 1). Thus, the evaluation ofmotor activity during test
and retest session suggests that neither sedation nor the reduction of
motivation to explore the apparatus were critical issues in this study.
Nonetheless, although not statistically signiﬁcant, there was an increase
in the distance traveled of MOD/SAL compared to the STD/SAL in test
session (Table 1). This ﬁnding might be due to the novel area available
for exploration by animals in the MOD/SAL group (which were trained
with partial blocking of the maze) compared to the STD/SAL group —
which was formerly habituated to the whole apparatus.
In short, data reported in the present study demonstrated that the
anxiolytic activity of DZP is critically important to the impairment of
extinction learning caused by this BDZ, but not to the aversive memory
retrieval. This retrieval seems to depend on an optimal anxiety level. In
view of the aforementioned results, the use of BDZs as a pharmacologi-
cal treatment of conditioned fear-related disorders should be carefully
reconsidered due to its potential impairing effect on aversive memory
extinction.
Nevertheless, further investigation is required to address the specu-
lative reasoning raised along the discussion. For instance, it would be
relevant to address the action of other classes of drugs — such as anti-
depressants or other anxiolytics, as well a possible role of state-
dependent learning under the protocol used here. Further, it would be
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the role of the HPA axis on aversive memory extinction.
Finally, we introduce a modiﬁed version of the PMDAT. This modiﬁ-
cation allows the evaluation of anxiety and retrieval/extinction of
aversive memory in the test and retest sessions to enable correlational
inferences between these variables. These features highlight the
PMDAT as a valuable model to study the interactions of learned and in-
nate fear components, which are imperative to understanding anxiety
disorders that comprise mnemonic components.
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